Cross Timbers Royalty Trust
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRT research report →
Price Chart
About the company
Cross Timbers Royalty Trust functions as an express trust within the United States, holding substantial stakes in various energy-related assets. The trust maintains a 90% net profits interest across a selection of producing and nonproducing royalty and overriding royalty properties located in Texas, Oklahoma, and New Mexico. Additionally, it secures a 75% net profits working interest in seven specific properties, four of which are situated in Texas and three in Oklahoma.
- CEO
- Nancy G. Willis
- IPO
- 1992
- HQ
- Dallas, TX, US
Get TickerSpark's AI analysis on CRT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $60.42M
- P/E
- 26.53
- PEG
- -0.45
- P/S
- 8.94
- P/B
- 28.43
- EV/EBITDA
- 23.73
- Div Yield
- 5.57%
- Gross Margin
- 45.00%
- Op Margin
- 34.12%
- Net Margin
- 50.42%
- ROE
- 154.70%
- ROIC
- 63.58%
Latest fiscal year · YoY change
- Revenue
- $5.79M-11.8%
- Gross Profit
- $5.51M-16.0%
- Op Income
- $4.49M
- Net Income
- $4.49M-20.9%
- EPS
- $0.75-21.1%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $11.10
- 52W Low
- $7.07
- 50D MA
- $9.76
- 200D MA
- $9.34
- Beta
- -0.02
- RSI (14)
- 56
- Avg Volume
- 19.98K
No earnings-call transcripts are available for CRT yet.
- Free Float
- 100.0%
- Shares Outstanding
- 6.00M
- Float Shares
- 6.00M
of shares held by institutions
23 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for CRT, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Virginia FoxxHouse · NC05 | Sell | Jan 17, 24 | Filing → |
| Virginia FoxxHouse · NC05 | Buy | Dec 8, 23 | Filing → |
| Virginia FoxxHouse · NC05 | Buy | Nov 28, 23 | Filing → |
| Virginia FoxxHouse · NC05 | Buy | Nov 29, 23 | Filing → |
| Virginia FoxxHouse · NC05 | Buy | Oct 2, 23 | Filing → |
| Virginia FoxxHouse · NC05 | Buy | Sep 19, 23 | Filing → |
| Virginia FoxxHouse · NC05 | Buy | May 17, 23 | Filing → |
| Virginia FoxxHouse · NC05 | Buy | May 1, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Softvest Advisors, LLC | 697.89K | ▲ 697.89K |
| Ashton Thomas Private Wealth, LLC | 239.92K | ▲ 11.87K |
| Beacon Pointe Advisors, LLC | 62.80K | ▲ 62.80K |
| Citadel Advisors LLC | 38.86K | ▲ 38.86K |
| Welch Group, LLC | 16.65K | ▲ 1.80K |
| Waddell & Associates, LLC | 15.91K | ▲ 144 |
| Marshall Wace, Llp | 11.03K | ▲ 11.03K |
| Ubs Group AG | 7.56K | ▼ 562 |
| Morgan Stanley | 6.19K | ▲ 1.75K |
| Wells Fargo & Company/Mn | 1.98K | 0 |
| Harbour Investments, Inc. | 1.80K | 0 |
| Bnp Paribas Arbitrage, Snc | 707 | ▲ 707 |
Held by 1 ETFs
Biggest fund positions in CRT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 12, 26 | OLIVER ERIC L | buy | 12,950 |
| Aug 11, 26 | OLIVER ERIC L | buy | 13,132 |
| Jun 25, 26 | OLIVER ERIC L | buy | 3,727 |
| Jun 24, 26 | OLIVER ERIC L | buy | 4,047 |
| Jun 23, 26 | OLIVER ERIC L | buy | 34,596 |
| Jun 22, 26 | OLIVER ERIC L | buy | 20,968 |
| Jun 2, 26 | OLIVER ERIC L | buy | 5,748 |
| Jun 1, 26 | OLIVER ERIC L | buy | 4,642 |
| May 29, 26 | OLIVER ERIC L | buy | 9,297 |
| May 26, 26 | OLIVER ERIC L | buy | 23,386 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CRT coverage
Recent articles, reports, and earnings notes.
No research on CRT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CRT report →CROSS TIMBERS ROYALTY TRUST DECLARES JULY CASH DISTRIBUTION
prnewswire.com · Jul 21
REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
gurufocus.com · Jul 18
CROSS TIMBERS ROYALTY TRUST DECLARES JUNE CASH DISTRIBUTION
prnewswire.com · Jun 18
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung
gurufocus.com · May 29
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
gurufocus.com · May 28
CROSS TIMBERS ROYALTY TRUST DECLARES MAY CASH DISTRIBUTION
prnewswire.com · May 18
The Iran War Sent Oil Above $100. These 3 Royalty Trusts Are Quietly Paying Double Digit Yields Because of It
247wallst.com · May 14
Innate Pharma Reports First Quarter 2026 Business Update and Financial Results
gurufocus.com · May 13
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.